Condition: Cardiac Amyloidosis · Sponsor: University of Leipzig
This is a clinical registry of patients with cardiac amyloidosis being treated at University Hospital Leipzig. The aim of the registry is to collect detailed information about clinical events, symptoms, imaging, biomarkers, comorbidities, and treatment from routine patient management which would not be provided by randomized clinical trails.
This description comes directly from the study's public registry record.
Daniel Lavall, MD · +493419712650 · daniel.lavall@medizin.uni-leipzig.de
Romy Gessner, MD · +493419712650 · romy.gessner@medizin.uni-leipzig.de
Always discuss trial participation with your own doctor first.
| University Hospital Leipzig | Leipzig, Saxony, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06129656